Cargando…
Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses
The extensive efforts around the globe are being made to develop a suitable vaccine against COVID-19 (Coronavirus Disease-19) caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2). An effective vaccine should be able to induce high titers of neutralizing antibodies to prevent the vi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301105/ https://www.ncbi.nlm.nih.gov/pubmed/32585611 http://dx.doi.org/10.1016/j.intimp.2020.106717 |